Team:EPF-Lausanne/Strategy

From 2009.igem.org

(Difference between revisions)
m (→Read out system)
 
(45 intermediate revisions not shown)
Line 3: Line 3:
<div CLASS="epfltrick">__TOC__
<div CLASS="epfltrick">__TOC__
</div>
</div>
-
<div CLASS="epfl09">
+
<div CLASS="epfl09incub">
 +
 
 +
<html><br>
 +
<br>
 +
<br><br><br>
 +
<br><center>
 +
 
 +
<a href="https://2009.igem.org/Team:EPF-Lausanne/LOVTAP"
 +
onMouseOver="document.MyImage7.src='https://static.igem.org/mediawiki/2009/thumb/d/d4/Theory_lov.jpg/100px-Theory_lov.jpg';" onMouseOut="document.MyImage7.src='https://static.igem.org/mediawiki/2009/thumb/5/52/Theory_lov_nb.jpg/100px-Theory_lov_nb.jpg';">
 +
<img src="https://static.igem.org/mediawiki/2009/thumb/5/52/Theory_lov_nb.jpg/100px-Theory_lov_nb.jpg" name="MyImage7"></a>
 +
 
 +
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 +
 
 +
<a href="https://2009.igem.org/Team:EPF-Lausanne/LOVTAP_Results"
 +
onMouseOver="document.MyImage6.src='https://static.igem.org/mediawiki/2009/thumb/b/ba/Results_lab.jpg/100px-Results_lab.jpg';" onMouseOut="document.MyImage6.src='https://static.igem.org/mediawiki/2009/thumb/f/f1/Results_lab_nb.jpg/100px-Results_lab_nb.jpg';">
 +
<img src="https://static.igem.org/mediawiki/2009/thumb/f/f1/Results_lab_nb.jpg/100px-Results_lab_nb.jpg" name="MyImage6"></a>
 +
 
 +
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 +
 
 +
<a href="https://2009.igem.org/Team:EPF-Lausanne/Future_directions" onMouseOver="document.MyImage5.src='https://static.igem.org/mediawiki/2009/thumb/5/5b/Future.jpg/100px-Future.jpg';" onMouseOut="document.MyImage5.src='https://static.igem.org/mediawiki/2009/thumb/c/cd/Future_nb.jpg/100px-Future_nb.jpg';">
 +
<img src="https://static.igem.org/mediawiki/2009/thumb/c/cd/Future_nb.jpg/100px-Future_nb.jpg" name="MyImage5"></a>
 +
 
 +
 
 +
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 +
 
 +
 
 +
<a href="https://2009.igem.org/Team:EPF-Lausanne/References" onMouseOver="document.MyImage9.src='https://static.igem.org/mediawiki/2009/thumb/a/a2/Ref.jpg/100px-Ref.jpg';" onMouseOut="document.MyImage9.src='https://static.igem.org/mediawiki/2009/thumb/2/25/Ref_nb.jpg/100px-Ref_nb.jpg';">
 +
<img src="https://static.igem.org/mediawiki/2009/thumb/2/25/Ref_nb.jpg/100px-Ref_nb.jpg" name="MyImage9"></a>
 +
 
 +
</center>
 +
</html>
 +
<br>
 +
----
 +
<br>
<html><center>
<html><center>
-
<font size="6" color="#007CBC"><i>Strategy</i></font>  
+
<font size="12" color="#007CBC">Strategy</font>  
</center></html>
</center></html>
<br>
<br>
----
----
-
<br>
 
<br>
<br>
==Cloning strategy==
==Cloning strategy==
-
Our aim was to create a biobrick containing LovTAP under the influcence of an inducible promoter. This part needed to contain (in order) the inducible promoter (LacI), RBS (ribosome binging site), the LovTAP gene (that we recovered from Dr. ?? Sosnick’s lab) and finally a terminator (Term). This entire part was of course to be flanked by the standard prefix (E,X) and suffix (S,P). In order to synthesize this part, we proceeded in three steps :
 
-
1. We ligated LovTAP with the terminator (we used a double terminator).
+
<font size="3">'''LovTap BioBrick'''</font>
-
2. We also ligated LacI with RBS.
+
Our aim was to create a biobrick containing LovTAP under the influence of an inducible promoter. This part needed to contain (in order) the inducible promoter (LacI), RBS (ribosome binding site), the LovTAP gene (that was generously sent by Pr. Sosnick form the University of Chicago) and finally a terminator (Term). This entire part was of course to be flanked by the standard prefix (E,X) and suffix (S,P). In order to synthesize this part, we proceeded in three steps :
-
3. Finally we ligated these two parts together to obtain our biobrick.
+
1. We ligated the LovTAP gene into the terminator (we used a double terminator).
-
[[Image: Biobricks.jpg|LovTAP construction]]
+
2. We also ligated LacI into RBS.
-
So finally we have :
+
3. Finally we ligated these two parts together to obtain our biobrick (LacI-RBS in the LovTAP-term part).
 +
 
 +
[[Image: LovTAP2.jpg|800 px|center|LovTAP construction]]
 +
 
 +
So finally we got :
[[Image: LovTAP.jpg|LovTAP]]
[[Image: LovTAP.jpg|LovTAP]]
-
With the biobrick, we have an inducible system : when we add IPTG, the promoter activates the expression of the LovTAP gene.
+
With this biobrick, we have an inducible system : when we add IPTG, the promoter activates the expression of the LovTAP protein.
-
==Read out system==
 
-
Once we have our protein LovTAP produced, we needed a read out system to assess whether the protein was functional.
 
-
We designed two different read out systems :
 
-
1. The read out 1 (RO1) contains the tryptophan operon followed by RBS, RFP and Term. In normal conditions, RFP should be expressed (so we should see some red fluorescence). This is because the Trp promoter is constituitively ON. The Trp repressor (TrpR) only binds to DNA if there is tryptophane available in the mediumnhibits. The activated LovTAP protein (when illuminated at 470 nm) binds to the Trp operon and repress the RFP gene, exaclty as theTrpR in presence of Trp would do. We should therefore observe a decrease in red fluorescence.
 
-
In order to characterize the read out, we tested it in different conditions : with or without TRP, with different amount of TRP. With adjunction of Trp, we would expect the fluorescence to decrease.
 
-
[[Image: RO1.jpg|RO1]]
+
<font size="3">'''Read-Out n°1 BioBrick'''</font>
-
2. The read out 2 (RO2) is composed of TRP op, RBS, TetR, Term and then TetRP, RBS, RFP and Term. It is a double repressor system : TrpR/LovTAP binds to the TRP operon, so repressing the expression of TetR. On the other hand, TetR (if expressed) inhibits the production of RFP by acting on the TetR promoter. The final result is that if LovTAP is active, red fluorescence should increase as RFP is expressed. TRP has the same effect as LovTAP but we also used ATC (anhydrotetracyclin) : ATC has the same effect as TRP, when it binds to TetR it prevents binding to its promoter sequence TetO ! When we add TRP and ATC, we should therefore have the same effect as with an active LovTAP : production of red fluorescence.
+
This BioBrick was synthesized using the protocol we developed with the Klenow fragment. To do this, two long primers which together contained the sequence for the Trp promoter were ordered; these primers could self-anneal in the reaction mix, and the second strands that were missing at the extremities of the primers were fully synthesized using the Klenow fragment, instead of a classic extension using the TAQ DNA Polymerase.
 +
For more information, here is the [https://2009.igem.org/wiki/index.php?title=Team:EPF-Lausanne/Protocols/Klenow complete protocol].
 +
 +
 +
 +
<font size="3">'''Read-Out n°2 BioBrick'''</font>
 +
 +
This BioBrick was created using our new method, which we named "1.5-step PCR". This method is similar to a 2-step PCR, however the difference is that in the 1.5-step, the first cycle of amplification is omitted, so that in the initial step we directly add the longer primers to amplify the DNA from the plasmid. The last step is the same as for the 2-step PCR, where you add the iGEM (short) primers to amplify the entire sequence, from the extremities of the long primers which had been added previously. By suppressing one step of the "classic" 2-step PCR protocol, it allows us to save a considerable amount of time.
 +
 +
For more details on this method, look at the [https://2009.igem.org/wiki/index.php?title=Team:EPF-Lausanne/Protocols/1.5_steps_PCR protocol].
 +
 +
==Read-Out systems==
 +
<div style="text-align:justify;">
 +
Once we have our protein LovTAP produced, we need a read out system to assess whether the protein was functional or not.
 +
Therefore, we designed two different read out systems :
 +
 +
'''1.''' The read out 1 (RO1) contains the tryptophan operon followed by RBS, RFP and Term. In normal conditions, RFP should be expressed (so we should see some red fluorescence). This is because the Trp promoter is constitutively ON. The Trp repressor (TrpR) only binds to DNA if there is tryptophane available in the medium. The activated LovTAP protein (when illuminated at 470 nm) binds to the Trp operon and repress the RFP gene, exactly as the TrpR in presence of Trp would do. We should therefore observe a decrease in red fluorescence.
 +
In order to characterize the read out, we tested it in different conditions : with or without TRP, with different amount of TRP. With addition of Trp, we would expect the fluorescence to decrease.
 +
 +
[[Image: RO1.jpg|RO1]]
 +
 +
'''2.''' The read out 2 (RO2) is composed of the Trp op, RBS, TetR (gene), Term and then TetR op, RBS, RFP and Term. It is a double repressor system : TrpR/LovTAP bind to the Trp op, therefore repressing the expression of the tetracyline repressor (TetR). On the other hand, TetR (if expressed) inhibits the production of RFP by acting on the TetR op. The final result is that, if LovTAP is active, red fluorescence should increase as RFP is expressed. Trp has the same effect as LovTAP. For the characterization of the system,  we also used ATC (anhydrotetracyclin). ATC inhibits the TetR protein, making it unable to bind to its operator sequence. Therefore, if present, it has the same effect has inhibiting the TetR protein synthesis. The overall effect is then the same as Trp(LovTAP), when it present, the fluoresence increases. Eventually, we have three ways of modulating the fluorescence : adding Trp, shining light (if LovTAP is present) and adding ATC would all make the red fluorescence to increase.
[[Image: RO2.jpg|RO2]]
[[Image: RO2.jpg|RO2]]
-
So all this function like this :
+
So everything together gives the following system :
 +
 
 +
[[Image: systems.jpg|800 px|center|Readouts]]
 +
 
 +
==Modeling==
 +
 
 +
In order to anticipate the output of the Read Out 2 system, we made a mathematical model of this circuit and solved this first order ordinary differential equation system.
 +
 
 +
The system was modeled as [https://2009.igem.org/wiki/index.php?title=Team:EPF-Lausanne/ODEmodeling explained here]
 +
 
 +
 
 +
[[Image:FluoRed.png‎|frame|center|Simulation of the Read Out 2 system and experimental data taken from  [https://2009.igem.org/Team:EPF-Lausanne/LOVTAP_Results#Characterization_of_the_entire_system Experiment N°2]]]
-
[[Image: Readouts.jpg|Readouts]]
 
Line 52: Line 113:
</html>  
</html>  
<br>
<br>
 +
</div>
</div><div CLASS="epfl09bouchon"></div>
</div><div CLASS="epfl09bouchon"></div>

Latest revision as of 16:33, 21 October 2009



Contents







                                               


Strategy


Cloning strategy

LovTap BioBrick

Our aim was to create a biobrick containing LovTAP under the influence of an inducible promoter. This part needed to contain (in order) the inducible promoter (LacI), RBS (ribosome binding site), the LovTAP gene (that was generously sent by Pr. Sosnick form the University of Chicago) and finally a terminator (Term). This entire part was of course to be flanked by the standard prefix (E,X) and suffix (S,P). In order to synthesize this part, we proceeded in three steps :

1. We ligated the LovTAP gene into the terminator (we used a double terminator).

2. We also ligated LacI into RBS.

3. Finally we ligated these two parts together to obtain our biobrick (LacI-RBS in the LovTAP-term part).

LovTAP construction

So finally we got :

LovTAP

With this biobrick, we have an inducible system : when we add IPTG, the promoter activates the expression of the LovTAP protein.


Read-Out n°1 BioBrick

This BioBrick was synthesized using the protocol we developed with the Klenow fragment. To do this, two long primers which together contained the sequence for the Trp promoter were ordered; these primers could self-anneal in the reaction mix, and the second strands that were missing at the extremities of the primers were fully synthesized using the Klenow fragment, instead of a classic extension using the TAQ DNA Polymerase.

For more information, here is the complete protocol.


Read-Out n°2 BioBrick

This BioBrick was created using our new method, which we named "1.5-step PCR". This method is similar to a 2-step PCR, however the difference is that in the 1.5-step, the first cycle of amplification is omitted, so that in the initial step we directly add the longer primers to amplify the DNA from the plasmid. The last step is the same as for the 2-step PCR, where you add the iGEM (short) primers to amplify the entire sequence, from the extremities of the long primers which had been added previously. By suppressing one step of the "classic" 2-step PCR protocol, it allows us to save a considerable amount of time.

For more details on this method, look at the protocol.

Read-Out systems

Once we have our protein LovTAP produced, we need a read out system to assess whether the protein was functional or not. Therefore, we designed two different read out systems :

1. The read out 1 (RO1) contains the tryptophan operon followed by RBS, RFP and Term. In normal conditions, RFP should be expressed (so we should see some red fluorescence). This is because the Trp promoter is constitutively ON. The Trp repressor (TrpR) only binds to DNA if there is tryptophane available in the medium. The activated LovTAP protein (when illuminated at 470 nm) binds to the Trp operon and repress the RFP gene, exactly as the TrpR in presence of Trp would do. We should therefore observe a decrease in red fluorescence. In order to characterize the read out, we tested it in different conditions : with or without TRP, with different amount of TRP. With addition of Trp, we would expect the fluorescence to decrease.

RO1

2. The read out 2 (RO2) is composed of the Trp op, RBS, TetR (gene), Term and then TetR op, RBS, RFP and Term. It is a double repressor system : TrpR/LovTAP bind to the Trp op, therefore repressing the expression of the tetracyline repressor (TetR). On the other hand, TetR (if expressed) inhibits the production of RFP by acting on the TetR op. The final result is that, if LovTAP is active, red fluorescence should increase as RFP is expressed. Trp has the same effect as LovTAP. For the characterization of the system, we also used ATC (anhydrotetracyclin). ATC inhibits the TetR protein, making it unable to bind to its operator sequence. Therefore, if present, it has the same effect has inhibiting the TetR protein synthesis. The overall effect is then the same as Trp(LovTAP), when it present, the fluoresence increases. Eventually, we have three ways of modulating the fluorescence : adding Trp, shining light (if LovTAP is present) and adding ATC would all make the red fluorescence to increase. RO2

So everything together gives the following system :

Readouts

Modeling

In order to anticipate the output of the Read Out 2 system, we made a mathematical model of this circuit and solved this first order ordinary differential equation system.

The system was modeled as explained here


Simulation of the Read Out 2 system and experimental data taken from Experiment N°2


Back to top


Retrieved from "http://2009.igem.org/Team:EPF-Lausanne/Strategy"